These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 38662121)
1. Infectious complications in pediatric patients undergoing CD19+CD22+ chimeric antigen receptor T-cell therapy for relapsed/refractory B-lymphoblastic leukemia. Wu X; Cao Z; Chen Z; Wang Y; He H; Xiao P; Hu S; Lu J; Li B Clin Exp Med; 2024 Apr; 24(1):87. PubMed ID: 38662121 [TBL] [Abstract][Full Text] [Related]
2. KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study. Shah BD; Ghobadi A; Oluwole OO; Logan AC; Boissel N; Cassaday RD; Leguay T; Bishop MR; Topp MS; Tzachanis D; O'Dwyer KM; Arellano ML; Lin Y; Baer MR; Schiller GJ; Park JH; Subklewe M; Abedi M; Minnema MC; Wierda WG; DeAngelo DJ; Stiff P; Jeyakumar D; Feng C; Dong J; Shen T; Milletti F; Rossi JM; Vezan R; Masouleh BK; Houot R Lancet; 2021 Aug; 398(10299):491-502. PubMed ID: 34097852 [TBL] [Abstract][Full Text] [Related]
3. [Clinical efficacy and safety of blinatumomab bridging CAR-T cell therapy in the treatment of patients with adult acute B-cell lymphoblastic leukemia]. Pu Y; Zhou XY; Liu Y; Kong X; Han JJ; Zhang J; Lin ZH; Chen J; Qiu HY; Wu DP Zhonghua Xue Ye Xue Za Zhi; 2024 Apr; 45(4):339-344. PubMed ID: 38951060 [No Abstract] [Full Text] [Related]
4. EEG features and synek scale indicate severity of neurotoxicity in adult patients treated with CD19 CAR T-cell therapy. Mao D; Reiner AS; Chen X; Park J; Pennisi M; Perales MA; Avila EK; Santomasso BD Sci Rep; 2024 Nov; 14(1):29090. PubMed ID: 39580601 [TBL] [Abstract][Full Text] [Related]
5. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs. Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602 [TBL] [Abstract][Full Text] [Related]
6. Safety and activity of CTX130, a CD70-targeted allogeneic CRISPR-Cas9-engineered CAR T-cell therapy, in patients with relapsed or refractory T-cell malignancies (COBALT-LYM): a single-arm, open-label, phase 1, dose-escalation study. Iyer SP; Sica RA; Ho PJ; Prica A; Zain J; Foss FM; Hu B; Beitinjaneh A; Weng WK; Kim YH; Khodadoust MS; Huen AO; Williams LM; Ma A; Huang E; Ganpule A; Nagar SD; Sripakdeevong P; Cullingford EL; Karnik S; Dequeant ML; Patel JN; He XS; Li Z; He QA; Mendonez JH; Keegan A; Horwitz SM Lancet Oncol; 2024 Nov; ():. PubMed ID: 39617017 [TBL] [Abstract][Full Text] [Related]
7. Chimeric Antigen Receptor T Cells Targeting CD19 and GCC in Metastatic Colorectal Cancer: A Nonrandomized Clinical Trial. Chen N; Pu C; Zhao L; Li W; Wang C; Zhu R; Liang T; Niu C; Huang X; Tang H; Wang Y; Yang H; Jia B; Jiang X; Han G; Wang W; Chen D; Wang Y; Rowinsky EK; Kennedy E; Lu VX; Cui G; Wu Z; Xiao L; Cui J JAMA Oncol; 2024 Nov; 10(11):1532-1536. PubMed ID: 39298141 [TBL] [Abstract][Full Text] [Related]
8. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone. Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924 [TBL] [Abstract][Full Text] [Related]
9. Genedrive kit for detecting single nucleotide polymorphism m.1555A>G in neonates and their mothers: a systematic review and cost-effectiveness analysis. Shabaninejad H; Kenny RP; Robinson T; Stoniute A; O'Keefe H; Still M; Thornton C; Pearson F; Beyer F; Meader N Health Technol Assess; 2024 Oct; 28(75):1-75. PubMed ID: 39487741 [TBL] [Abstract][Full Text] [Related]
10. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model. Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661 [TBL] [Abstract][Full Text] [Related]
11. Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early-stage Hodgkin's lymphoma. Goldkuhle M; Kreuzberger N; von Tresckow B; Eichenauer DA; Specht L; Monsef I; Skoetz N Cochrane Database Syst Rev; 2024 Dec; 12(12):CD007110. PubMed ID: 39620432 [TBL] [Abstract][Full Text] [Related]
12. Qualitative evidence synthesis informing our understanding of people's perceptions and experiences of targeted digital communication. Ryan R; Hill S Cochrane Database Syst Rev; 2019 Oct; 10(10):ED000141. PubMed ID: 31643081 [TBL] [Abstract][Full Text] [Related]
13. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences. Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159 [TBL] [Abstract][Full Text] [Related]
14. What Are the Functional, Radiographic, and Survivorship Outcomes of a Modified Cup-cage Technique for Pelvic Discontinuity? Mu W; Xu B; Wahafu T; Wang F; Guo W; Zou C; Cao L Clin Orthop Relat Res; 2024 Dec; 482(12):2149-2160. PubMed ID: 38991223 [TBL] [Abstract][Full Text] [Related]
15. BCMA CAR-T therapy combined with pomalidomide is a safe and effective treatment for relapsed/refractory multiple myeloma. Yan Y; Tu Y; Cheng Q; Zhang J; Wang E; Deng Z; Yu Y; Wang L; Liu R; Chu L; Kang L; Liu J; Li X J Transl Med; 2024 Nov; 22(1):1087. PubMed ID: 39614361 [TBL] [Abstract][Full Text] [Related]
16. OUTREACH: phase 2 study of lisocabtagene maraleucel as outpatient or inpatient treatment at community sites for R/R LBCL. Linhares Y; Freytes CO; Cherry M; Bachier C; Maris M; Hoda D; Varela JC; Bellomo C; Cross S; Essell J; Fanning S; Terebelo H; Yimer H; Courtright J; Sharman JP; Kostic A; Vedal M; Ogasawara K; Avilion A; Espinola R; Yuan B; Mattar B Blood Adv; 2024 Dec; 8(23):6114-6126. PubMed ID: 39347584 [TBL] [Abstract][Full Text] [Related]
17. Diabetes as a risk factor for tuberculosis disease. Franco JV; Bongaerts B; Metzendorf MI; Risso A; Guo Y; Peña Silva L; Boeckmann M; Schlesinger S; Damen JA; Richter B; Baddeley A; Bastard M; Carlqvist A; Garcia-Casal MN; Hemmingsen B; Mavhunga F; Manne-Goehler J; Viney K Cochrane Database Syst Rev; 2024 Aug; 8(8):CD016013. PubMed ID: 39177079 [TBL] [Abstract][Full Text] [Related]
18. Case report: CD7-targeted autologous CAR-T therapy for the treatment of T-cell acute lymphoblastic leukemia undergoing allogeneic peripheral blood stem cell transplantation in the long-term follow-up. Li LL; Xia YP; Li Q; Wang P; Sun PP; Wang XG; Zhang R Front Immunol; 2024; 15():1469251. PubMed ID: 39620223 [TBL] [Abstract][Full Text] [Related]
19. Vitamin D supplementation for women during pregnancy. Palacios C; Kostiuk LL; Cuthbert A; Weeks J Cochrane Database Syst Rev; 2024 Jul; 7(7):CD008873. PubMed ID: 39077939 [TBL] [Abstract][Full Text] [Related]
20. Tamoxifen for adults with hepatocellular carcinoma. Naing C; Ni H; Aung HH Cochrane Database Syst Rev; 2024 Aug; 8(8):CD014869. PubMed ID: 39132750 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]